The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?
Great advances have been made in describing the intracellular pathways and genes that are activated by bacterial products. New definitions and therapies for sepsis will be based on such cellular and genetic alterations. In particular, in 2051 sepsis will no longer be defined simply as a clinical con...
Guardat en:
| Publicat a: | Crit Care |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2002
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137301/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12225594/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/cc1506 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|